International Journal of Artificial Organs 2006-12-01

Enhanced dermal regeneration using modified collagen scaffolds: experimental porcine study.

M P Markowicz, G C M Steffens, P C Fuchs, N Pallua

Index: Int. J. Artif. Organs 29(12) , 1167-73, (2006)

Full Text: HTML

Abstract

Ongoing research has achieved much progress towards the development of new artificial skin substitute products. However, effective implant material for correcting full-thickness defects (such as those arising from extensive burns, tumor resection, hereditary or congenital defects and chronic wounds) has not yet become available. Following split-thickness skin grafting, contraction and scar formation are unavoidable. These phenomena are believed to be due to poor dermis regeneration. Collagen dermis substitute has been developed for the treatment of deep, poorly vascularized tissue defects. However, their application is problematic, because scaffolds of this kind fail to adequately induce the neoangiogenesis needed for regeneration. To overcome these shortcomings a number of matrices have been chemically modified. Furthermore, these matrices first require implantation and follow-up by skin grafting 3 to 5 weeks later. In this article we describe new materials made of modified collagen which enhance dermal regeneration and neoangiogenesis. The procedure was applied in successfully dealing with full-thickness defects in pigs, with subsequent split-thickness skin grafting being performed immediately afterwards. Histological findings revealed that the neodermis obtained resembles a normal dermis structure. These scaffolds have the potential of serving as an off-the-shelf skin replacement in the reconstruction of deep wounds, thus supporting wound-healing processes.


Related Compounds

Related Articles:

A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers.

2013-12-01

[Dermatol. Surg. 39(12) , 1758-66, (2013)]

An attempt to improve diagnostics of contact allergy due to epoxy resin systems. First results of the multicentre study EPOX 2002.

2004-01-01

[Contact Dermatitis 51(5-6) , 263-72, (2004)]

Chemical mutagenesis testing in Drosophila. IX. Results of 50 coded compounds tested for the National Toxicology Program.

1994-01-01

[Environ. Mol. Mutagen. 23(1) , 51-63, (1994)]

Influence of the morphology of poly(EGDMA-co-HEMA) on the chemical modifications and retention of O-phosphothreonine.

2003-01-31

[J. Biochem. Biophys. Methods 55(1) , 23-36, (2003)]

1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.

2011-06-01

[Mol. Biosyst. 7(6) , 2055-65, (2011)]

More Articles...